Berman Tabacco Investigates Potential Claims Against Humana
Berman Tabacco, a prominent national law firm catering to investors, has initiated an investigation into Humana, Inc. This inquiry centers around allegations that the company may have engaged in unlawful kickbacks to insurance brokers. Such actions could potentially lead to significant claims from shareholders.
About the Allegations
The investigation stems from serious allegations that were unveiled following intervention by the U.S. Attorney's Office for the District of Massachusetts. The case began as whistleblower claims and indicates that Humana might have paid tens of millions—up to $250 million in kickbacks between 2016 and 2021—to insurance brokers like Select Quote, in exchange for steering clients toward Humana's Medicare products. This unsettling situation has led to a notable decline in Humana's stock value, declining around 3% upon the filing of the allegations.
Impact on Investors
These allegations have raised significant concerns about the level of oversight by Humana's board of directors. The law firm is particularly focused on assessing whether the officers and directors of Humana have breached their fiduciary duties to stockholders. This investigation is crucial for investors seeking to understand the implications of these potentially unethical actions on their investments.
Contact Information
For those interested in gaining further information regarding this investigation, Berman Tabacco encourages current stockholders of Humana to reach out. Whether via phone at 800-516-9926 or through email correspondence at law@bermantabacco.com, the firm is prepared to assist in addressing any inquiries.
About Berman Tabacco
Established in 1982, Berman Tabacco has built a formidable reputation in the realm of securities litigation, having represented numerous investors in a diverse array of cases. Their commendable work has earned them accolades as a Top Plaintiffs' Firm by notable rankings such as Benchmark Litigation. Furthermore, both Chambers USA and The Legal 500 have acknowledged the firm's expertise in handling complex securities litigation, enhancing confidence in their capabilities.
Frequently Asked Questions
What is the focus of Berman Tabacco's investigation into Humana?
The investigation considers allegations that Humana engaged in illegal kickbacks to insurance brokers, potentially impacting shareholder value.
How can investors obtain more information about the investigation?
Investors can contact Berman Tabacco via phone at 800-516-9926 or email at law@bermantabacco.com for further details.
What are the potential implications for Humana's stockholders?
Shareholders could be affected by the findings of the investigation, especially if fiduciary duties are found to have been breached.
What prior recognition has Berman Tabacco received?
The firm has been recognized as a Top Plaintiffs' Firm and has received several accolades for its work in securities litigation.
When did the allegations against Humana come to light?
The allegations were first raised by a whistleblower and later unsealed with the help of the U.S. Attorney's Office, highlighting the serious nature of the claims.
